• Dasatinib Monohydrate and NET Biology in CML

  2026-10-07

  Dasatinib Monohydrate, also known as BMS-354825, is examined here through a distinct immunobiology lens: how kinase inhibition intersects with neutrophil extracellular traps in chronic myeloid leukemia. The analysis separates established target activity from emerging evidence on NET-associated vascular biology and defines appropriate translational limits.

• Ibuprofen: A Mechanism-to-Evidence Research Framework

  2026-10-07

  Ibuprofen is examined here as a mechanistic research tool rather than a generic anticancer agent. The article connects COX biology, colon cancer evidence, assay interpretation, and the distinct protein-binding insights from a mubritinib–albumin study.

• Pifithrin-α: Interpreting p53–Ferroptosis Evidence

  2026-10-06

  Pifithrin-α is a p53 inhibitor that helps researchers test whether p53 contributes causally to ferroptosis and neurotoxicity. This evidence-focused analysis explains what the 2025 deltamethrin study shows, where interpretation remains limited, and how PFTα fits broader apoptosis and radiation-response research.

• Kaempferol, NRF2, and Inflammatory Osteolysis

  2026-10-06

  A 2026 study identifies NRF2 as a direct molecular target of kaempferol and connects NRF2/HO-1 activation with reduced osteoclast activity, oxidative stress, and inflammatory bone loss. Its combination of binding, pathway, cellular, and animal evidence supports a mechanistic model, while the single disease model and pharmacological validation leave important questions about clinical transferability.

• Ran Lactylation, SIRT1, and Astrocyte Polarization

  2026-10-05

  A 2026 International Immunopharmacology study identifies Ran lactylation at lysine 123 as a non-histone mechanism linking lactate accumulation to STAT3 nuclear transport and astrocyte polarization after oxygen-glucose deprivation/reoxygenation. The findings extend lactylation research beyond histones while indicating that SIRT1 is an important regulator of this metabolic-epigenetic pathway in spinal cord injury models.

• CGRP/SP–Piezo2 Signaling in Trigeminal Neuralgia

  2026-10-05

  Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 feedback loop that connects trigeminal root compression, neuroinflammation, and mechanical allodynia in a rat model of trigeminal neuralgia. The study provides a mechanistic framework for peripheral sensitization while also highlighting the limits of translating findings from rat trigeminal tissues to human disease.

• Microspheres Reshape the TME to Boost TIL Therapy

  2026-10-04

  Li et al. report alginate-based microspheres that combine hyaluronidase and CXCL9 to remodel the tumor microenvironment before tumor collection. In mouse models, this pretreatment increased TIL recovery and supported faster expansion, stronger cytotoxic activity, and improved antitumor effects after reinfusion.

• Mitomycin C: From DNA Damage to Drug Repurposing

  2026-10-03

  Mitomycin C is an antitumor antibiotic whose DNA-reactive activity can be interpreted alongside apoptosis signaling and drug-repurposing evidence. This article connects product-level cancer research findings with L1000-based polypharmacology while clarifying key limits on translation.

• RITA (NSC 652287): From Assay Signal to Translation

  2026-10-02

  RITA (NSC 652287) offers a mechanistically distinctive way to study p53 pathway activation, DNA cross-linking, and tumor-cell response. This thought-leadership guide shows how translational researchers can move beyond single-point viability data by integrating time-resolved assays, orthogonal apoptosis measurements, and tumor xenograft models.

• AZ505: Designing Better SMYD2 Assays

  2026-10-01

  AZ505 is a substrate-competitive SMYD2 inhibitor suited to mechanistic epigenetic regulation research. This guide shows how to connect enzyme potency, selectivity, cellular methylation, and disease-model phenotypes without overinterpreting any single assay.

• OsCPK4–OsCNGC7 Feedback Loop in Rice Salt Tolerance

  2026-10-01

  The reference study identifies an OsCPK4–OsCNGC7 phosphorylation-centered module that regulates salt-triggered Ca2+ influx in rice. Its time-dependent mechanism links early channel activation with later signal attenuation, offering a framework for understanding how plants balance rapid salt defense with growth recovery.

• VE-822 ATR Inhibitor Workflow for DDR Research

  2026-09-30

  VE-822 is a potent ATR inhibitor for dissecting replication-stress signaling and testing radiation or gemcitabine combinations in pancreatic cancer models. This workflow connects biochemical potency with target-engagement assays, 2D/3D validation, and patient-informed experimental design.

• Cyclic Pifithrin-α: Mapping p53 in Neuroinflammation

  2026-09-30

  Cyclic Pifithrin-α hydrobromide is a research tool for separating p53-dependent stress responses from downstream inflammatory and mechanosensory signaling. This article develops an evidence-bounded assay strategy inspired by new CGRP/SP–Piezo2 findings in trigeminal pain research.

• AZ505 for SMYD2 Inhibitor Workflows

  2026-09-29

  AZ505 enables mechanism-first studies of substrate-competitive SMYD2 inhibition, connecting biochemical methyltransferase assays with renal fibrosis and oncology models. This practical guide covers assay design, cellular translation, selectivity controls, and troubleshooting for reproducible epigenetic regulation research.

• JNJ-26854165: From p53 Mechanism to Translation

  2026-09-29

  JNJ-26854165, also known as Serdemetan, offers a mechanistically focused way to study HDM2-dependent p53 regulation in cancer models. Its translational value becomes clearer when researchers separate proliferative arrest from cell death, align assay endpoints with mechanism, and treat radiation combination studies as model-specific hypotheses rather than clinical predictions.

8657 records 1/578 page Next 12345 下5页 Last page